Phase I study of sorafenib plus ifosfamide in patients with advanced soft tissue and bone sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study.

被引：0
|
作者：
Garcia del Muro, X.
Lopez-Pousa, A.
Martin Broto, J.
Cubedo, R.
Jimenez Colomo, L.
Gallego, O.
Prevencio-Pulla, M.
机构：
[1] Inst Catalan Oncol, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[3] Hosp Son Dureta, Palma De Mallorca, Spain
[4] Hosp Puerta de Hierro, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10024
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II trial of ifosfamide in combination with sorafenib in patients with advanced soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study.
    Garcia del Muro, Xavier
    Maurel, Joan
    Martinez Trufero, Javier
    Lavernia, Javier
    Lopez-Pousa, Antonio
    De Las Penas, Ramon
    Cubedo, Ricardo
    Fra, Joaquin
    Casado, Antonio
    De Juan, Ana
    Jimenez Colomo, Laura
    Martin Broto, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study
    J. Martín-Liberal
    A. López-Pousa
    J. Martín Broto
    R. Cubedo
    O. Gallego
    E. Brendel
    O. M. Tirado
    X. García del Muro
    Investigational New Drugs, 2014, 32 : 287 - 294
  • [3] Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study
    Martin-Liberal, J.
    Lopez-Pousa, A.
    Martin Broto, J.
    Cubedo, R.
    Gallego, O.
    Brendel, E.
    Tirado, O. M.
    Garcia del Muro, X.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 287 - 294
  • [4] Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study
    Xavier García del Muro
    Joan Maurel
    Javier Martínez Trufero
    Javier Lavernia
    Antonio López Pousa
    Ramón de las Peñas
    Ricardo Cubedo
    José Pablo Berros
    Antonio Casado Herráez
    Ana de Juan
    Javier Martín Broto
    Investigational New Drugs, 2018, 36 : 468 - 475
  • [5] Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study
    Garcia del Muro, Xavier
    Maurel, Joan
    Martinez Trufero, Javier
    Lavernia, Javier
    Lopez Pousa, Antonio
    de las Penas, Ramn
    Cubedo, Ricardo
    Pablo Berros, Jose
    Casado Herraez, Antonio
    de Juan, Ana
    Martin Broto, Javier
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (03) : 468 - 475
  • [6] Phase II study of gemcitabine (GEM) plus sirolimus (SIR) in previously treated patients with advanced soft tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
    Garcia del Muro, Xavier
    Lopez-Pousa, Antonio
    Martinez-Trufero, Javier
    Martin Broto, Javier
    Cubedo, Ricardo
    Lavernia, Javier
    Redondo, Andres
    Lopez-Martin, Jose A.
    Mulet-Margalef, Nuria
    Sanjuan, Xavier
    Tirado, Oscar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
    Martin-Liberal, Juan
    Lopez-Pousa, Antonio
    Martinez-Trufero, Javier
    Martin-Broto, Javier
    Cubedo, Ricardo
    Lavernia, Javier
    Redondo, Andres
    Antonio Lopez-Martin, Jose
    Mulet-Margalef, Nuria
    Sanjuan, Xavier
    Tirado, Oscar M.
    Garcia-del-Muro, Xavier
    TARGETED ONCOLOGY, 2018, 13 (01) : 81 - 87
  • [8] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
    Juan Martin-Liberal
    Antonio López-Pousa
    Javier Martínez-Trufero
    Javier Martín-Broto
    Ricardo Cubedo
    Javier Lavernia
    Andrés Redondo
    José Antonio López-Martín
    Nùria Mulet-Margalef
    Xavier Sanjuan
    Òscar M. Tirado
    Xavier Garcia-del-Muro
    Targeted Oncology, 2018, 13 : 81 - 87
  • [9] Activity of doxorubicin after high-dose ifosfamide in adult patients with advanced soft tissue sarcoma: A study of the Spanish Group for Research on Sarcomas (GEIS)
    Buesa, JM
    Fra, J
    Anton, A
    Lopez-Pousa, A
    Martin, J
    del Muro, JG
    Escudero, P
    Casado, A
    Poveda, A
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 783 - 785
  • [10] Phase I study of sirolimus plus gemcitabine in patients with advanced solid tumors: A Spanish Group for Research on Sarcomas (GEIS) study
    Martin Liberal, Juan
    Gil, Marta
    Jimenez, Laura
    Ochoa de Olza, Maria
    Munoz, Carmen
    Gonzalo, Nuria
    Rigo, Raul
    Colom, Helena
    Sainz Jaspeado, Miguel
    Tirado, Oscar M.
    Garcia del Muro, Xavier
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345